Abstract
Although extracellular Ca2+ entry through the voltage-dependent Ca2+ channels plays an important role in the spontaneous phasic contractions of the pregnant rat myometrium, the role of the T-type Ca2+ channels has yet to be fully identified. The aim of this study was to investigate the role of the T-type Ca2+ channel in the spontaneous phasic contractions of the rat myometrium. Spontaneous phasic contractions and [Ca2+]i were measured simultaneously in the longitudinal strips of female Sprague-Dawley rats late in their pregnancy (on day 18~20 of gestation: term=22 days). The expression of T-type Ca2+ channel mRNAs or protein levels was measured. Cumulative addition of low concentrations (< 1 μM) of nifedipine, a L-type Ca2+ channel blocker, produced a decrease in the amplitude of the spontaneous Ca2+ transients and contractions with no significant change in frequency. The mRNAs and proteins encoding two subunits (α 1G, α 1H) of the T-type Ca2+ channels were expressed in longitudinal muscle layer of rat myometrium. Cumulative addition of mibefradil, NNC 55-0396 or nickel induced a concentration-dependent inhibition of the amplitude and frequency of the spontaneous Ca2+ transients and contractions. Mibefradil, NNC 55-0396 or nickel also attenuated the slope of rising phase of spontaneous Ca2+ transients consistent with the reduction of the frequency. It is concluded that T-type Ca2+ channels are expressed in the pregnant rat myometrium and may play a key role for the regulation of the frequency of spontaneous phasic contractions.
Go to : 

REFERENCES
Asokan KT., Sarkar SN., Mishra SK., Raviprakash V. Effects of mibefradil on uterine contractility. Eur J Pharmacol. 455:65–71. 2002.


Billman GE. Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation. Eur J Pharmacol. 229:179–187. 1992.


Blanks AM., Zhao ZH., Shmygol A., Bru-Mercier G., Astle S., Thornton S. Characterization of the molecular and electrophysiological properties of the T-type calcium channel in human myometrium. J Physiol. 581(Pt 3):915–926. 2007.


Challis JRG., Matthews SG., Gibb W., Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocrine Rev. 21:514–550. 2000.


Chien EK., Saunders T., Phillippe M. The mechanisms underlying Bay K 8644-stimulated phasic myometrial contractions. J Soc Gynecol Invest. 3:106–112. 1996.


Chow KY., Wu C., Sui GP., Fry CH. Role of the T-type Ca2+ current on the contractile performance of guinea pig detrusor smooth muscle. Neurourol Urodyn. 22:77–82. 2003.
Coleman HA., Hart JDE., Tonta MA., Parkington HC. Changes in the mechanisms involved in uterine contractions during pregnancy in guinea-pigs. J Physiol. 523:785–798. 2000.


Coleman HA., Parkington HC. The role of membrane potential in the control of uterine motility. Carsten ME, Miller JD, editors. ed,. Uterine function: Molecular and cellular aspects. New York: Plenum Press;p. p. 195–248. 1990.
Collins PL., Moore JJ., Idriss E., Kulp TM. Human fetal membranes inhibit calcium L-channel activated uterine contractions. Am J Obstet Gynecol. 175:1173–1179. 1996.


Doerr T., Denger R., Trautwein W. Calcium currents in single SA nodal cells of the rabbit heart studied with action potential clamp. Pflugers Arch. 413:599–603. 1989.


Honore E., Amedee T., Martin C., Dacquet C., Mironneau C., Mironneau J. Calcium channel current and its sensitivity to (+) isradipine in cultured pregnant rat myometrial cells. Pflugers Arch. 414:477–483. 1989.
Huang L., Keyser BM., Tagmose TM., Hansen JB., Taylor JT., Zhuang H., Zhang M., Ragsdale DS., Li M. NNC 55-0396[(1S,2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphytyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Therap. 309:193–199. 2004.
Inoue Y., Sperelakis N. Gestational change in Na+ and Ca2+ current densities in rat myometrial smooth muscle cells. Am J Physiol. 260:C658–C663. 1991.
Jmari K., Mironneau C., Mironneau J. Inactivation of calcium channels current in rat uterine smooth muscle: evidence for calcium and voltage-mediated mechanisms. J Physiol. 380:111–126. 1986.
Knock GA., Aaronson PI. Calcium antagonistic properties of the cyclooxygenase-2 inhibitor nimesulide in human myometrial myocytes. Br J Pharmacol. 127:1470–1478. 1999.


Lee JH., Gomora JC., Cribbs LL., Perez-Reyes E. Nickel block of three cloned T-type calcium channels: low concentrations selectively block α1H. Biophys J. 77:3034–3042. 1999.


Mershon JL., Mikala G., Schwartz A. Changes in the expression of the L-type voltage-dependent calcium channel during pregnancy and parturition in the rat. Biol Reprod. 51:993–999. 1994.
Mironneau J. Excitation-contraction coupling in voltage clamped uterine smooth muscle. J Physiol. 233:127–141. 1973.


Mishra SK., Hermsmeyer K. Selective inhibition of T-type Ca2+ channels by Ro 40-5967. Circ Res. 75:144–148. 1994.
Ohkubo T., Kawarabayashi T., Inoue Y., Kitamura K. Differential expression of L-and T-type calcium channels between longitudinal and circular muscles of the rat myometrium during pregnancy. Gynecol Obstet Invest. 59:80–85. 2005.
Ohya Y., Sperelakis N. Fast Na+ and slow Ca2+ channels in single uterine muscle cells from pregnant rats. Am. J Physiol. 257:C408–C412. 1989.
Parkington HC., Coleman HA. Ionic mechanisms underlying action potentials in myometrium. Clin Exp Pharmacol Physiol. 15:657–665. 1988.


Parkington HC., Coleman HA. Excitability in uterine smooth muscle. Front Horm Res. 27:179–200. 2001.


Parkington HC., Tonta MA., Brennecke SP., Coleman HA. Contractile activity, membrane potential, and cytoplasmic calcium in human uterine smooth muscle in the third trimester of pregnancy and during labor. Am J Obstet Gynecol. 181:1145–1151. 1999.


Perez-Reyes E. Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev. 83:117–161. 2003.


Riemer RK., Heymann MA. Regulation of uterine smooth muscle function during gestation. Pediatrics Res. 44:615–627. 1998.


Shmigol AV., Eisner DA., Wray S. Properties of voltage-activated [Ca2+]i transients in single smooth muscle cells isolated from pregnant rat uterus. J Physiol. 511:803–811. 1998.
Sui GP., Wu C., Fry CH. Inward calcium currents in cultured and freshly isolated detrusor muscle cells: evidence of a T-type calcium current. J Urol. 165:621–626. 2001.
Taggart MJ., Tribe RM. Cellular ionic mechanisms controlling uterine smooth muscle contraction: effects of gestational state. Savineau JP, editor. ed,. New Frontiers in Smooth Muscle Biology and Physiology. India: Research Signpost;p. p. 523–549. 2007.
Tytgat J., Vereecke J., Carmeliet E. Combined study of sodium current and T-type calcium current in isolated cardiac cells. Pflugers Arch. 417:142–148. 1990.
Wray S., Jones K., Kupittayanant S., Li Y., Matthew A., Monir-Bishty E., Noble K., Pierce SJ., Quenby S., Shmygol AV. Calcium signaling and uterine contractility. J Soc Gynecol Invest. 10:252–264. 2003.
Yeon DS., Kim JS., Ahn DS., Kwon SC., Kang BS., Morgan KG., Lee YH. Role of protein kinase C- or RhoA-induced Ca2+ sensitization in stretch-induced myogenic tone. Cardiovas Res. 53:431–438. 2002.
Go to : 

![]() | Fig. 1.Effect of removing external Ca2+ and nifedipine on spontaneous Ca2+ transients and contractions. (A, B) Effect of removing external Ca2+ (0-Ca2+) and 1 μM nifedipine on spontaneous Ca2+ transients and contractions. Representative recoding (C) and statistical evaluation (D) showing the concentration-response curve obtained by cumulative addition of low concentrations of nifedipine. Data are expressed as relative percentage of the control (amplitude before treatment of nifedipine). Results are expressed as mean±SEM of six experiments. ∗Control vs Nifedipine (p<0.05). |
![]() | Fig. 2.Expression of mRNAs and proteins for α subunits (α1G and α1H) of T-type Ca2+ channel in longitudinal muscle layer of pregnant rat myometrium. Representative data of RT/PCR (A) and western blot (B). Immunoblots are representative of four independent preparations. The PCR was performed with 35 cycles and PCR products were followed by electrophoresis on a 1% agarose gel. |
![]() | Fig. 3.Dose-response curve for the effect of T-type Ca2+ channel blockers on the spontaneous Ca2+ transients and contractions. (A1, B1, C1) Concentration-related reduction of the amplitude and frequency of spontaneous Ca2+ transients. (A2, B2, C2) concentration-related reduction of the amplitude and frequency of spontaneous contractions. Mibefradil (A), NNC 55-0396 (B), and nickel (C) were added cumulatively. Data are expressed as relative percentage of control (amplitude before treatment of blockers). Results are expressed as mean±SEM of seven experiments. ∗Control vs Blockers, ∗∗Amplitude vs Frequency (p<0.05). |
![]() | Fig. 4.Representative recording for the effect of T-type Ca2+ channel blockers on spontaneous Ca2+ transients and contractions. Spontaneous Ca2+ transients (top) and contractions (bottom) before and during 1 μM mibefradil (A), 5 μM NNC 55-0396 (B), and 100 μM nickel (C) application. Data are representative of ten independent preparations. |
![]() | Fig. 5.Effect of the T-type Ca2+ channel blockers on the frequency and slope of rising phase of spontaneous Ca2+ transients. Superimposed spontaneous Ca2+ transients under control conditions and in presence of 1 μM Mibefradil (A), 5 μM NNC 55-0396 (B), and 100 μM nickel (C), respectively. Each blocker was added in the bath solution after spontaneous Ca2+ transients were stable. Statistical evaluation (D) showing the Ca2+ ratio and frequency obtained by adding mibefradil, NNC 55-0396, and nifedipine. Data are expressed as relative percentage of control. Results are expressed as mean±SEM of six experiments. |
![]() | Fig. 6.Effect of (A) nifedipine (1 μM), (B) mibefradil (1 μM), (C) NNC 55-0396 (5 μM), and (D) nickel (100 μM) on the 70 mM KCl-induced increase in [Ca2+]i and force. All drugs were added for 10 min before 70 mM KCl-induced contraction. Data are representative of seven~nine independent preparations. |